Highlander Capital Management, LLC Cocrystal Pharma, Inc. Transaction History

Highlander Capital Management, LLC

  • $245 Million
  • Q1 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2019

Aug 14, 2019
SELL
$2.06 - $2.75 $683 - $913
-332 Closed
0 $0
Q1 2018

May 16, 2018
BUY
$3.9 - $6.9 $1,294 - $2,290
332 New
332 $2,000

About Cocrystal Pharma, Inc.

COCP Quotes by TradingView
  • Ticker COCP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 8,122,420
  • Market Cap $17.9M
  • Description
  • Cocrystal Pharma, Inc., a biotechnology company, focuses on the discovery and development of antiviral therapeutic treatments for serious and/or chronic viral diseases. It employs structure-based technologies to create antiviral drugs primarily to treat hepatitis C virus (HCV), influenza virus, coronavirus, and norovirus infections. The company ...
More about COCP
Track This Portfolio

Track Highlander Capital Management, LLC Portfolio

Follow Highlander Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Highlander Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Highlander Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email